UBS Initiates Coverage On Teladoc Health with Neutral Rating, Announces $90 Price Target

UBS analyst Kevin Caliendo initiates coverage on Teladoc Health (NYSE:TDOC) with a Neutral rating and a $90 price target.

Benzinga · 01/10/2020 13:07

UBS analyst Kevin Caliendo initiates coverage on Teladoc Health (NYSE:TDOC) with a Neutral rating and a $90 price target.